{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "mesh:D009336",
      "entity_text" : "necrosis",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:681",
      "entity_text" : "dopamine",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "The primary therapeutic choice in prolactinoma is medical treatment with dopamine agonists that reduce the size of prolactinoma by inducing a reduction in cell volume, as well as causing perivascular fibrosis, partial cell necrosis, and reduce cellular DNA synthesis [XREF_BIBR].",
  "reading_complete" : "2020-08-02T18:38:28Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T18:36:37Z",
  "trigger" : "reduce",
  "evidence" : [ "dopamine agonists that reduce the size of prolactinoma by inducing a reduction in cell volume, as well as causing perivascular fibrosis, partial cell necrosis" ],
  "pmc_id" : "4330017",
  "score" : 0
}